NCT04415983

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Study of Novel Triple Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori in Children

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

Detailed description

Study of Novel triple Nitazoxanide (NTZ) based new therapeutic regimens for Helicobacter pylori in children

Conditions

• Helicobacter Pylori Infection

Interventions

Type	Name	Description
DRUG	Nitazoxanide	Nitazoxanide twice daily
DRUG	Clarithromycin	Klacid twice daily
DRUG	Metronidazole	Metronidazole twice daily
DRUG	Proton pump inhibitor	Omeprazoe twice daily

Timeline

• Start date: 2020-06-01
• Primary completion: 2030-10-01
• Completion: 2030-12-01
• First posted: 2020-06-04
• Last updated: 2020-06-04

Locations

1 site across 1 country: Egypt